FTY720 Blocks Egress of T Cells in Part by Abrogation of Their Adhesion on the Lymph Node Sinus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FTY720 Blocks Egress of T Cells in Part by Abrogation of Their Adhesion on the Lymph Node Sinus

Published:2011-07-25 Issue:5 Volume:187 Page:2244-2251
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Zhi Liang,Kim Pilhan,Thompson Brian D.,Pitsillides Costas,Bankovich Alexander J.,Yun Seok-Hyun,Lin Charles P.,Cyster Jason G.,Wu Mei X.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference35 articles.

1. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

2. FTY720: Sphingosine 1-Phosphate Receptor-1 in the Control of Lymphocyte Egress and Endothelial Barrier Function

3. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice

4. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

5. The immunosuppressant FTY720 down‐regulates sphingosine 1‐phosphate G protein‐coupled receptors

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanical loading of joint modulates T cells in lymph nodes to regulate osteoarthritis;Osteoarthritis and Cartilage;2023-12

2. Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1;OncoImmunology;2023-06-15

3. Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis;Pharmacology & Therapeutics;2023-06

4. Delayed Activation of T Cells at the Site of Infection Facilitates the Establishment of Trypanosoma cruzi in Both Naive and Immune Hosts;mSphere;2023-02-21

5. Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy;Nature Cancer;2023-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3